Biosimilar Antibodies & Proteins
In this product category, you will find reports and other services providing you with the most uptodate business and competitive intelligence information on biosimilar antibodies and proteins. The range of products covers industry data as well as in-depth strategic assessment and analysis of biosimilar antibody and protein companies, R&D pipeline, and sales and market information.
Showing all 2 results
- February of 2019This report provides an overview of isolated and recombinant asparaginase enzymes on the market or in development for treatment of leukemia and solid tumors.€ 100.00
- December of 2018Information about R&D projects is identified and retrieved from company publications including, but not limited to, press releases, presentations, website disclosures, SEC publications, regulatory documents, scientific abstracts and full papers,...